glp-1 for diabetic Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Clinical Focus on GLP-1 Agonists

Coles LD, Tuite PJ, Oz G, Mishra UR, Kartha RV, Sullivan KM, et al

N-acetylcysteine (NAC) is a building block of glutathione, but it is also dependent on the bodys ability to make glutathione, which varies greatly with age and health status

Dose sensitivity is a common reason for customization

Klimas have found that intranasal glutathione helps in about 80 90% of their patients producing about a 20% improvement in fatigue and cognition

Proper nutrition is extremely important for people taking GLP-1 medications

The insurance question, and why it rarely settles the duration problem A reasonable objection to all of this: why treat GLP-1 treatment as a cash expense at all, when insurance exists